Current Drug Targets


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Editorial [Hot Topic: Pancreatic Cancer: Between Bench and Bedside (Guest Editors: Davide Melisi and Alfredo Budillon)] promotion: free to download

Volume:13   Issue: 6
Pp: 729-730
Davide Melisi and Alfredo Budillon
DOI: 10.2174/138945012800564130
Published on: 03 May, 2012

Molecular and Genetic Bases of Pancreatic Cancer

Volume:13   Issue: 6
Pp: 731-743
Vanja Vaccaro, Alain Gelibter, Emilio Bria, Pierluigi Iapicca, Paola Cappello, Francesca Di Modugno, Maria Simona Pino, Carmen Nuzzo, Francesco Cognetti, Francesco Novelli, Paola Nistico and Michele Milella
DOI: 10.2174/138945012800564077
Published on: 03 May, 2012

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation open access plus

Volume:13   Issue: 6
Pp: 744-752
Vincenzo Corbo, Giampaolo Tortora and Aldo Scarpa
DOI: 10.2174/138945012800564103
Published on: 03 May, 2012

Is Preoperative Endoscopic Biliary Drainage Indicated for Jaundiced Patients with Resectable Pancreatic Cancer?

Volume:13   Issue: 6
Pp: 753-763
Mario de Bellis, Raffaele Palaia, Claudia Sandomenico, Elena Di Girolamo, Marco Cascella and Francesco Fiore
DOI: 10.2174/138945012800564167
Published on: 03 May, 2012

Pancreatic Cancer Surgery: The State of the Art

Volume:13   Issue: 6
Pp: 764-771
Song Cheol Kim, Young Hoon Kim, Kwang Min Park and Young Ju Lee
DOI: 10.2174/138945012800564185
Published on: 03 May, 2012

Vascular Resection in Pancreaticoduodenectomy: Is it Worthwhile?

Volume:13   Issue: 6
Pp: 772-780
Francesco Bianco, Cinzia Sassaroli, Paolo Delrio, Silvia De Franciscis and Giovanni Romano
DOI: 10.2174/138945012800564121
Published on: 03 May, 2012

Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas

Volume:13   Issue: 6
Pp: 781-788
Robert A. Wolff
DOI: 10.2174/138945012800564086
Published on: 03 May, 2012

Evidences and Opinions for Adjuvant Therapy in Pancreatic Cancer

Volume:13   Issue: 6
Pp: 789-794
Michele Reni
DOI: 10.2174/138945012800564176
Published on: 03 May, 2012

Conventional Chemotherapy of Advanced Pancreatic Cancer

Volume:13   Issue: 6
Pp: 795-801
Francesco Giuliani, Massimo Di Maio, Giuseppe Colucci and Francesco Perrone
DOI: 10.2174/138945012800564149
Published on: 03 May, 2012

Targeting EGFR in Pancreatic Cancer Treatment

Volume:13   Issue: 6
Pp: 802-810
T. Troiani, E. Martinelli, A. Capasso, F. Morgillo, Michele Orditura, F. De Vita and F. Ciardiello
DOI: 10.2174/138945012800564158
Published on: 03 May, 2012

Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics

Volume:13   Issue: 6
Pp: 811-828
Ross A. Soo, Wei-Peng Yong and Federico Innocenti
DOI: 10.2174/138945012800564068
Published on: 03 May, 2012

To Cardiovascular Disease and Beyond: New Therapeutic Perspectives of Statins in Autoimmune Diseases and Cancer

Volume:13   Issue: 6
Pp: 829-841
Chary Lopez-Pedrera, Patricia Ruiz-Limon, Araceli Valverde-Estepa, Nuria Barbarroja and Antonio Rodriguez-Ariza
DOI: 10.2174/138945012800564112
Published on: 03 May, 2012

Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders

Volume:13   Issue: 6
Pp: 842-862
Luca Antonioli, Rocchina Colucci, Concettina La Motta, Marco Tuccori, Oriana Awwad, Federico Da Settimo, Corrado Blandizzi and Matteo Fornai
DOI: 10.2174/138945012800564095
Published on: 03 May, 2012

Apixaban: A New Player in the Anticoagulant Class

Volume:13   Issue: 6
Pp: 863-875
Ritesh Agrawal, Pratima Jain and S. N. Dikshit
DOI: 10.2174/138945012800564059
Published on: 03 May, 2012